Trial Evaluating Efficacy and Safety of Nivolumab (Optivo®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort.
Clinical trial NCT04343144 · UNKNOWN
Trial details
- NCT number
- NCT04343144
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-15
- Primary completion
- 2020-07-31
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.